1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]
 
IJPMBS 2024 Vol.13(2): 67-73
doi: 10.18178/ijpmbs.13.2.67-73

A Review of Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder and Focused Discussion of Anxiety Comorbidity in ADHD

Yilin Li
School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK
Email: yl252@st-andrews.ac.uk

Manuscript received December 10, 2023; revised January 10, 2024; accepted January 19, 2024; published June 21, 2024.

Abstract—This review examines the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD), focusing on longitudinal treatment effects of medication and behavioural treatments for children with ADHD, and delves into the often-overlooked aspect of anxiety comorbidity. Initiated in the 1990s, the study spans over 16 years, documenting various treatment effects on symptom severity and social functions of children with ADHD. The findings suggest that while medication is generally more effective for ADHD, current treatments do not fully normalize patients. The paper emphasizes ADHD as a developmental disorder causing ongoing executive function impairment and emotional burdens for patients and their families. Notably, it addresses ADHD's multiple comorbidities, with a central focus on anxiety comorbidity, which contributes to behavioural and academic challenges and can impair functioning into adulthood. The review combs the main findings from the MTA study and its follow-ups based on time sequence, offering insights into optimizing ADHD treatments. The interplay of ADHD and anxiety symptoms and their joint impact on treatment effectiveness are critically analyzed. This paper not only sheds light on the complexities of treating ADHD, particularly in the presence of anxiety comorbidity but also highlights the need for more focused research in this area to develop more effective, tailored treatment strategies. 

Keywords—attention deficit hyperactivity disorder, multimodal treatment study, anxiety, comorbidity, psychostimulant, behavioural treatment

Cite: Yilin Li, "A Review of Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder and Focused Discussion of Anxiety Comorbidity in ADHD," International Journal of Pharma Medicine and Biological Sciences, Vol. 13, No. 2, pp. 67-73, 2024.

Copyright © 2024 by the authors. This is an open access article distributed under the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits use, distribution and reproduction in any medium, provided that the article is properly cited, the use is non-commercial and no modifications or adaptations are made.
Copyright © 2012-2024 International Journal of Pharma Medicine and Biological Sciences, All Rights Reserved
E-mail: ijpmbs@ejournal.net